INTRODUCTION Injections with filler agents are becoming increasingly popular as a treatment for wrinkles and for soft tissue augmentation. While there are many options for use with fillers, hyaluronic acid…

The goal of residency program at New York Presbyterian Hospital-Weill Cornell Medical Center is to train physicians to be world-class providers of dermatologic care with the highest ethical standards and…

Beyond Eyelash Lengthening:Prostaglandin Analogues for Scalp and EyebrowsScalp alopecias continue to be a challenge to clinicians and cause a major impact on a person's quality of life. Treatment options are…

FDA Approves VALCHLOR Ceptaris Therapeutics, Inc., has announced that the FDA has granted marketing approval for the orphan drug VALCHLORTM (mechlorethamine) gel for the topical treatment of stage IA and…

An Open Label Study Employing the Topical Immunomodulator Diphenylcyclopropenone in a Stabilized Gel to Treat Cutaneous Metastases Sponsored by Rockefeller University, This is an open label study to determine the…

INTRODUCTION Skin cancer is the most common form of cancer worldwide. Basal cell carcinoma (BCC) is the most common type of skin cancer,1,2 with an estimated 1.3 to 1.5 million…

The treatment of basal cell carcinoma (BCC) has remained largely unchanged for the past 50 years. Recently, the use of immunomodulators such as imiquimod have been used to treat early…

INTRODUCTIONBasal cell carcinoma (BCC) is frequently associated with mutations in the s (PTCH) gene leading to dysregulation of the hedgehog (Hh) pathway.1-3 This mutation is seen in more than 90%…

INTRODUCTION While the overwhelming majority of basal cell carcinoma (BCC) is effectively managed with surgery, causing minimal distress to the patient, individuals whose BCC has metastasized or progressed to an…

INTRODUCTION Approximately 2.8 million basal cell carcinomas (BCCs) occur in the United States each year, accounting for 80% of all non-melanoma skin cancers (NMSC); but fewer than 1,000 patients will…

The future of lasers and energy-based technologies lay in expanding their application to the delivery of compounds or drugs. By combining technologies with drug delivery, efficacy of either therapeutic modality…